MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/circresaha.116.309598

Медицинская библиотека · Circulation research · 2016

CD45 Expression in Mitral Valve Endothelial Cells After Myocardial Infarction.

Bischoff Joyce, Casanovas Guillem, Wylie-Sears Jill, Kim Dae-Hee, Bartko Philipp E, Guerrero J Luis, Dal-Bianco Jacob P, Beaudoin Jonathan, Garcia Michael L, Sullivan Suzanne M, Seybolt Margo M, Morris Brittan A, Keegan Joshua, Irvin Whitney S, Aikawa Elena, Levine Robert A

СтатьяПеревод в очереди

Аннотация

RATIONALE: Ischemic mitral regurgitation, a complication after myocardial infarction (MI), induces adaptive mitral valve (MV) responses that may be initially beneficial but eventually lead to leaflet fibrosis and MV dysfunction. We sought to examine the MV endothelial response and its potential contribution to ischemic mitral regurgitation.

OBJECTIVE

Endothelial, interstitial, and hematopoietic cells in MVs from post-MI sheep were quantified. MV endothelial CD45, found post MI, was analyzed in vitro.

METHODS AND

RESULTS

Ovine MVs, harvested 6 months after inferior MI, showed CD45, a protein tyrosine phosphatase, colocalized with von Willebrand factor, an endothelial marker. Flow cytometry of MV cells revealed significant increases in CD45+ endothelial cells (VE-cadherin+/CD45+/α-smooth muscle actin [SMA]+ and VE-cadherin+/CD45+/αSMA- cells) and possible fibrocytes (VE-cadherin-/CD45+/αSMA+) in inferior MI compared with sham-operated and normal sheep. CD45+ cells correlated with MV fibrosis and mitral regurgitation severity. VE-cadherin+/CD45+/αSMA+ cells suggested that CD45 may be linked to endothelial-to-mesenchymal transition (EndMT). MV endothelial cells treated with transforming growth factor-β1 to induce EndMT expressed CD45 and fibrosis markers collagen 1 and 3 and transforming growth factor-β1 to 3, not observed in transforming growth factor-β1-treated arterial endothelial cells. A CD45 protein tyrosine phosphatase inhibitor blocked induction of EndMT and fibrosis markers and inhibited EndMT-associated migration of MV endothelial cells.

CONCLUSIONS

MV endothelial cells express CD45, both in vivo post MI and in vitro in response to transforming growth factor-β1. A CD45 phosphatase inhibitor blocked hallmarks of EndMT in MV endothelial cells. These results point to a novel, functional requirement for CD45 phosphatase activity in EndMT. The contribution of CD45+ endothelial cells to MV adaptation and fibrosis post MI warrants investigation.

Для цитирования: Bischoff Joyce, Casanovas Guillem, Wylie-Sears Jill, Kim Dae-Hee, Bartko Philipp E, Guerrero J Luis, Dal-Bianco Jacob P, Beaudoin Jonathan, Garcia Michael L, Sullivan Suzanne M, Seybolt Margo M, Morris Brittan A, Keegan Joshua, Irvin Whitney S, Aikawa Elena, Levine Robert A. CD45 Expression in Mitral Valve Endothelial Cells After Myocardial Infarction.. Circulation research. 2016. DOI: 10.1161/circresaha.116.309598.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.